Working… Menu

Bioequivalence Evaluation of a New and Current Tablet of ASP015K

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02531191
Recruitment Status : Completed
First Posted : August 24, 2015
Last Update Posted : September 16, 2019
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 15, 2015
Actual Study Completion Date : July 15, 2015